Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AOMR | Common Stock, par value $0.01 per share ("Common Stock") | Purchase | $395K | +30.4K | +0.42% | $12.99 | 7.34M | May 20, 2022 | See footnotes | F1, F2 |
transaction | AOMR | Common Stock | Purchase | $87.6K | +6.26K | +0.09% | $13.99 | 7.34M | May 23, 2022 | See footnotes | F1, F2 |
transaction | AOMR | Common Stock | Purchase | $210K | +15K | +0.2% | $13.99 | 7.36M | May 24, 2022 | See footnotes | F1, F2 |
transaction | AOMR | Common Stock | Purchase | $472K | +33.8K | +0.46% | $13.99 | 7.39M | May 24, 2022 | See footnotes | F1, F2 |
Id | Content |
---|---|
F1 | The securities reported on this line are held directly by Xylem Finance LLC, a Delaware limited liability company ("Xylem"). Davidson Kempner Capital Management LP, a Delaware limited partnership and a registered investment adviser with the U.S. Securities and Exchange Commission ("DKCM") acts as investment manager to Xylem. DKCM GP LLC, a Delaware limited liability company, is the general partner of DKCM. The managing members of DKCM are Anthony A. Yoseloff, Eric P. Epstein, Conor Bastable, Shulamit Leviant, Morgan P. Blackwell, Patrick W. Dennis, Gabriel T. Schwartz, Zachary Z. Altschuler, Joshua D. Morris, Suzanne K. Gibbons and Zachary E. Gozali. Anthony A. Yoseloff through DKCM, is responsible for the voting and investment decisions relating to the securities held by Xylem reported herein. |
F2 | The filing of this statement shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. |